A study to evaluate the safety and efficacy of ketorolac for the treatment of inflammation and pain associated with cataract surgery

Trial Profile

A study to evaluate the safety and efficacy of ketorolac for the treatment of inflammation and pain associated with cataract surgery

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Oct 2009

At a glance

  • Drugs Ketorolac (Primary)
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Sponsors Allergan
  • Most Recent Events

    • 23 Jun 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jan 2008 The expected completion date for this trial is now 1 Dec 2008.
    • 17 Dec 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top